Journal of Neurology Research, ISSN 1923-2845 print, 1923-2853 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Neurol Res and Elmer Press Inc
Journal website https://www.neurores.org

Original Article

Volume 12, Number 3, October 2022, pages 121-127


The Impact of Atrial Fibrillation on the Outcome of Ischemic Stroke Treated With Thrombolysis or Endovascular Therapy

Figure

Figure 1.
Figure 1. The algorithm of study design.

Tables

Table 1. Demographic Data, Vascular Risk Factors and Baseline Assessments: Patient Classification According to Those With and Without Atrial Fibrillation
 
VariablesAF- (n = 524)AF+ (n = 196)P value
aMeasure is continuous (results are mean and standard deviation). AF: atrial fibrillation; AF-: without atrial fibrillation; AF+: with atrial fibrillation; EVT: endovascular therapy; mRS: modified Rankin Scale; NIHSS: National Institutes of Health Stroke Scale; SBP: systolic blood pressure; TIA: transient ischemic attack.
Agea66.9 (15.2)78.2 (12.5)< 0.0001
Sex (female)227 (43.3%)109 (55.6%)0.004
White417 (82.7%)166 (88.8%)0.03
Asian28 (5.6%)10 (5.3%)
Black/African American53 (10.5%)7 (3.7%)
Native American2 (0.4%)3 (1.6%)
Pacific Islander1 (0.2%)1 (0.5%)
Not Hispanic/Latino412 (78.6%)155 (79.1%)0.79
Hispanic/Latino108 (20.6%)38 (19.4%)
Current smoker84 (16%)6 (3.1%)< 0.0001
Hypertension348 (66.4%)146 (74.5%)0.10
Diabetes128 (24.4%)42 (21.4%)0.46
Coronary artery disease94 (17.9%)46 (23.5%)0.18
Congestive heart failure50 (9.5%)42 (21.4%)0.0001
Stroke/TIA122 (23.3%)46 (23.5%)0.57
Anticoagulants4 (0.8%)6 (3.1%)0.05
Baseline SBPa150.7 (25.6)150.6 (26)0.93
Baseline glucosea133 (46.6)141.3 (64.8)0.11
NIHSS > 5 at baseline338 (64.6%)151 (77.4%)0.001
Baseline mRS > 246 (9%)39 (20.3%)< 0.0001
EVT61 (11.6%)39 (19.9%)0.006
Thrombolysis435 (83%)140 (71.4%)0.0008
Thrombolysis and EVT28 (5.3%)17 (8.7%)0.14

 

Table 2. A Comparison Between the Rate of Successful Recanalization and Hemorrhagic Transformation in Cases With and Without Atrial Fibrillation: The Result of Adjusted Logistics Regression
 
VariablesTICI < 2bsICH
OR (CI)POR (CI)P
aFemale. bNever smoked or ex-smoker. cSeverity was defined as baseline NIHSS > 5. dDisability was defined as baseline modified Rankin Scale > 2. P-values less than 0.0001 are reported as zero. TICI: thrombolysis in cerebral infarction; sICH: symptomatic intracranial hemorrhage; CHF: congestive heart failure; OR: odds ratio; CI: confidence interval; SBP: systolic blood pressure; AF+: with atrial fibrillation.
Age0.96 (0.9 - 1.02)0.16371.02 (0.99 - 1.06)0.1909
Sexa0.19 (0.04 - 0.92)0.03920.65 (0.26 - 1.64)0.365
SBP1.03 (1 - 1.06)0.04291.01 (0.99 - 1.02)0.515
Smokersb0.22 (0.02 - 3.01)0.25872.04 (0.52 - 7.93)0.3059
Glucose1 (0.99 - 1.02)0.54511 (1 - 1.01)0.3189
Severityc4.71 (0.44 - 50.88)0.20152.99 (0.84 - 10.61)0.0899
Disabilityd0.91 (0.14 - 6.06)0.92170.39 (0.08 - 1.81)0.2285
CHF1.97 (0.26 - 14.96)0.51381.78 (0.61 - 5.26)0.294
Anticoagulants0.64 (0.05 - 7.9)0.73060 (0 - Inf)0.9878
AF+1.19 (0.29 - 4.84)0.80971.18 (0.44 - 3.17)0.7433

 

Table 3. A Comparison Between Discharge Disposition and Poststroke Disability in Cases With and Without Atrial Fibrillation: The Result of Adjusted Logistics Regression
 
VariablesDischarge dispositionModified Rankin Scale
Hospice/SNF/deathIn-hospital deathHospice/SNF0 - 2 vs. 3 - 60 - 2 vs. 3 - 50 - 2 vs. 6 (death)
OR (CI)POR (CI)POR (CI)POR (CI)POR (CI)POR (CI)P
aFemale. bNever smoked or ex-smoker. cSeverity was defined as baseline NIHSS > 5. dDisability was defined as baseline modified Rankin Scale > 2. P-values less than 0.0001 are reported as zero. SBP: systolic blood pressure; AF+: with atrial fibrillation; CHF: congestive heart failure; OR: odds ratio; CI: confidence interval; SNF: skilled nursing facility; TICI: thrombolysis in cerebral infarction.
Age1.04 (1.02 - 1.06)01.04 (1.01 - 1.06)0.01171.04 (1.02 - 1.07)00.97 (0.96 - 0.98)00.98 (0.96 - 0.99)0.00290.95 (0.93 - 0.97)0
Sexa1.03 (0.67 - 1.57)0.89131.15 (0.59 - 2.22)0.68461.03 (0.63 - 1.68)0.90261.02 (0.71 - 1.46)0.93151.05 (0.71 - 1.55)0.80980.81 (0.46 - 1.42)0.4615
SBP1.01 (1.01 - 1.02)0.00151.01 (1 - 1.02)0.11291.02 (1.01 - 1.03)0.00161 (0.99 - 1)0.24871 (0.99 - 1)0.37181 (0.98 - 1.01)0.4421
Smokersb1.1 (0.55 - 2.19)0.79040.4 (0.09 - 1.84)0.23821.49 (0.7 - 3.16)0.29820.85 (0.5 - 1.46)0.55690.77 (0.44 - 1.36)0.36451.53 (0.56 - 4.18)0.4086
Glucose1 (1 - 1)0.36011 (1 - 1.01)0.14621 (1 - 1)0.79291 (1 - 1)0.32041 (1 - 1)0.41 (1 - 1)0.8785
Severityc6.61 (3.68 - 11.87)06.73 (2.51 - 18.05)0.00027.06 (3.52 - 14.13)00.22 (0.15 - 0.33)00.28 (0.18 - 0.43)00.12 (0.05 - 0.26)0
Disabilityd1.24 (0.7 - 2.19)0.46390.9 (0.36 - 2.26)0.82981.41 (0.75 - 2.64)0.28190.13 (0.06 - 0.28)00.15 (0.07 - 0.35)00.11 (0.04 - 0.27)0
CHF1.87 (1.05 - 3.32)0.0331.68 (0.71 - 3.98)0.23952.04 (1.07 - 3.9)0.03080.7 (0.41 - 1.2)0.19970.67 (0.37 - 1.21)0.18640.66 (0.3 - 1.43)0.2923
Anticoagulants3.7 (0.75 - 18.27)0.10794.77 (0.4 - 56.63)0.21543.85 (0.66 - 22.53)0.13541.25 (0.31 - 5.11)0.75211.82 (0.34 - 9.74)0.48391.36 (0.14 - 12.84)0.7906
AF+1 (0.63 - 1.59)0.99980.95 (0.46 - 1.97)0.89320.96 (0.56 - 1.63)0.86930.73 (0.48 - 1.11)0.14030.75 (0.47 - 1.2)0.22840.67 (0.37 - 1.21)0.1853